# The Effect of Testosterone Replacement on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Hypogonadotrophic Hypogonadism

> **NCT01533129** · PHASE4 · COMPLETED · sponsor: **Gulhane School of Medicine** · enrollment: 106 (actual)

## Conditions studied

- Hypogonadotrophic Hypogonadism

## Interventions

- **DRUG:** Testogel 50 mg transdermal gel
- **DRUG:** Testosterone 250mg injection

## Key facts

- **NCT ID:** NCT01533129
- **Lead sponsor:** Gulhane School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2011-04
- **Final completion:** —
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2020-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01533129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01533129, "The Effect of Testosterone Replacement on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Hypogonadotrophic Hypogonadism". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01533129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*